Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-CHOICE4: Stent and DAPT Strategy in ACS
NCT05066789Phase 4Terminated
- Sponsor
- Samsung Medical Center
- Start
- Jan 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel in acute coronary syndrome (ACS), sponsored by Samsung Medical Center. Started Jan 2022; status: terminated.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05066789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066789.